Computational annotationFunctional evidence
These terms are computationally inferred by eggNOG-mapper and should not be interpreted as experimental validation in avocado.
- eggNOG
- Preferred name: LOC110796350 | Seed ortholog: 337451.A0A3S3NGN5 | COG: S | eggNOG OG: Cir_N@131567|p-7, zf-CCHC_6@2759|A-1
- Gene Ontology
- GO:0000122 negative regulation of transcription by RNA polymerase II; GO:0000209 protein polyubiquitination; GO:0000976 transcription cis-regulatory region binding; GO:0000979 RNA polymerase II core promoter sequence-specific DNA binding; GO:0001091 RNA polymerase II general transcription initiation factor binding; GO:0001181 RNA polymerase I general transcription initiation factor activity; GO:0002039 p53 binding; GO:0003674 molecular_function; GO:0003677 DNA binding; GO:0003682 chromatin binding; GO:0004402 histone acetyltransferase activity; GO:0004672 protein kinase activity; GO:0004674 protein serine/threonine kinase activity; GO:0005515 protein binding; GO:0005634 nucleus; GO:0006357 regulation of transcription by RNA polymerase II; GO:0006361 transcription initiation at RNA polymerase I promoter; GO:0006366 transcription by RNA polymerase II; GO:0006367 transcription initiation at RNA polymerase II promoter; GO:0006511 ubiquitin-dependent protein catabolic process; GO:0006974 DNA damage response; GO:0007140 male meiotic nuclear division; GO:0008150 biological_process; GO:0008270 zinc ion binding; GO:0009792 embryo development ending in birth or egg hatching; GO:0010629 negative regulation of gene expression; GO:0016251 RNA polymerase II general transcription initiation factor activity; GO:0016301 kinase activity; GO:0016922 nuclear receptor binding; GO:0017025 TBP-class protein binding; GO:0030901 midbrain development; GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process; GO:0034644 cellular response to UV; GO:0042789 mRNA transcription by RNA polymerase II; GO:0043565 sequence-specific DNA binding; GO:0045893 positive regulation of DNA-templated transcription; GO:0045944 positive regulation of transcription by RNA polymerase II; GO:0046777 protein autophosphorylation; GO:0046982 protein heterodimerization activity; GO:0048589 developmental growth; GO:0050821 protein stabilization; GO:0051123 RNA polymerase II preinitiation complex assembly; GO:0060090 molecular adaptor activity; GO:0060261 positive regulation of transcription initiation by RNA polymerase II; GO:0061628 histone H3K27me3 reader activity; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding; GO:0061631 ubiquitin conjugating enzyme activity; GO:0061733 protein-lysine-acetyltransferase activity; GO:0071318 cellular response to ATP; GO:0140046 histone H4K16ac reader activity; GO:0140416 transcription regulator inhibitor activity; GO:0140566 histone reader activity; GO:0160207 positive regulation of androgen receptor signaling pathway; GO:1901796 regulation of signal transduction by p53 class mediator; GO:1901797 negative regulation of signal transduction by p53 class mediator; GO:1902806 regulation of cell cycle G1/S phase transition; GO:1905524 negative regulation of protein autoubiquitination; GO:1990841 promoter-specific chromatin binding; GO:2000059 negative regulation of ubiquitin-dependent protein catabolic process
- KEGG
- EC: ec:2.3.1.48, ec:2.7.11.1 | KO: K06066 | Pathway: 03022, 03040 | BRITE: 00001